Todd C. Brady
2015
In 2015, Todd C. Brady earned a total compensation of $1.1M as President and Chief Executive Officer at Aldeyra Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $144,000 |
|---|---|
| Option Awards | $528,034 |
| Salary | $400,000 |
| Other | $4,564 |
| Total | $1,076,598 |
Brady received $528K in option awards, accounting for 49% of the total pay in 2015.
Brady also received $144K in non-equity incentive plan, $400K in salary and $4.6K in other compensation.
Rankings
In 2015, Todd C. Brady's compensation ranked 7,590th out of 13,638 executives tracked by ExecPay. In other words, Brady earned more than 44.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,590 out of 13,638 | 44th |
Division Manufacturing | 2,874 out of 5,190 | 45th |
Major group Chemicals And Allied Products | 1,037 out of 1,854 | 44th |
Industry group Drugs | 835 out of 1,528 | 45th |
Industry Pharmaceutical Preparations | 656 out of 1,182 | 45th |
Source: SEC filing on April 24, 2017.
Brady's colleagues
We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2015.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019